Translational studies on the vascular targeting agent Combretastatin A4 phosphate

Translational studies on the vascular targeting agent Combretastatin A4 phosphate

Bibliographic Details
Main Author:	Galbraith, Susan Mary
Published:	University College London (University of London) 2001
Subjects:	610 Magnetic resonance imaging
Online Access:	http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.367600

Similar Items

Haemoxugenase in tumours and its role in vascular targetting with combretastatin A4 phosphate
by: Khelefi, Amel Feriel
Published: (2003)

Combination therapy studies with the vascular disruptive agent combretastatin-a4-phosphate (CA4P)
by: Gaya, A. M.
Published: (2009)

Comparative Preclinical Pharmacokinetic and Metabolic Studies of the Combretastatin Prodrugs Combretastatin A4 Phosphate and A1 Phosphate.
by: Loadman, Paul M., et al.
Published: (2009)

MR indicators of structure and function in the rat brain and kidney in vivo
by: Burdett, Newman Grenville
Published: (1995)

Localized fast field-cycling NMR relaxometry
by: Pine, Kerrin J.
Published: (2014)

Nuclear magnetic resonance force microscopy of ammonium dihydrogen phosphate and magnetism of cobalt nanocrystals
by: Mirsaidov, Utkur
Published: (2008)

Studies of cerebral laterality in early onset schizophrenia
by: Collinson, Simon Lowes
Published: (2001)

Magnetic resonance imaging in vascular biology☆
by: Matthias Voehringer, et al.
Published: (2008-02-01)

Aptamer-conjugated magnetic nanoparticles as targeted magnetic resonance imaging contrast agent for breast cancer
by: Mohammad Keshtkar, et al.
Published: (2016-01-01)

Glucosamine Conjugated Gadolinium (III) Oxide Nanoparticles as a Novel Targeted Contrast Agent for Cancer Diagnosis in MRI
by: T Mortezazadeh, et al.
Published: (2020-02-01)

New MR imaging techniques in epilepsy
by: Wieshmann, Udo Carl
Published: (2000)

Non-Invasive Evaluation of Acute Effects of Tubulin Binding Agents: A Review of Imaging Vascular Disruption in Tumors
by: Li Liu, et al.
Published: (2021-04-01)

Stimulation of Eryptosis by Combretastatin A4 Phosphate Disodium (CA4P)
by: Elena Signoretto, et al.
Published: (2016-03-01)

Vascular CT and MRI: a practical guide to imaging protocols
by: D. J. Murphy, et al.
Published: (2018-03-01)

Reconstruction and analysis of 4D heart motion from tagged MR images.
Published: (2003)

A pilot evaluation of magnetic resonance imaging characteristics seen with solid papillary carcinomas of the breast in 4 patients
by: Lina Zhang, et al.
Published: (2017-08-01)

Liver-targeted liposomes for codelivery of curcumin and combretastatin A4 phosphate: preparation, characterization, and antitumor effects
by: Jiang H, et al.
Published: (2019-03-01)

Biocompatible Nanocomplexes for Molecular Targeted MRI Contrast Agent
by: Yu Dexin, et al.
Published: (2009-01-01)

The Present View of the Correlation of Breast Vascular Calcifications with Coronary Artery Calcifications
by: D. A. Bazhenova, et al.
Published: (2021-06-01)

Subtraction images: A really helpful tool in non-vascular MRI
by: Mohamed Eid, et al.
Published: (2014-09-01)

MR coronary artery imaging : assessment and implications of flow and motion
by: Keegan, Jennifer
Published: (1999)

Use of contrast agents with fast field-cycling magnetic resonance imaging
by: Ó hÓgáin, Dara
Published: (2011)

Iron Oxide Nanoparticles as Theranostic Agents in Cancer Immunotherapy
by: Rossella Canese, et al.
Published: (2021-07-01)

Multispectral Imaging for Metallic Biopsy Marker Detection During MRI-Guided Breast Biopsy: A Feasibility Study for Clinical Translation
by: Sarah Eskreis-Winkler, et al.
Published: (2021-03-01)

Exploring Diverse-Ring Analogues on Combretastatin A4 (CA-4) Olefin as Microtubule-Targeting Agents
by: Ming-Yu Song, et al.
Published: (2020-03-01)

Editorial: The Cerebellum: From Vascular Disease to Neurodegeneration
by: Sirio Cocozza
Published: (2021-02-01)

Preclinical Activity of the Vascular Disrupting Agent OXi4503 against Head and Neck Cancer
by: Katelyn D. Bothwell, et al.
Published: (2016-01-01)

Preparation and Properties of Tumor-Targeting MRI Contrast Agent Based on Linear Polylysine Derivatives
by: Xuanrong Sun, et al.
Published: (2019-04-01)

Diagnosis of hepatocellular carcinoma: Which MRI contrast agent? Which diagnostic criteria?
by: So Yeon Kim
Published: (2020-07-01)

Vascular anomalies
by: Julia Roka, et al.
Published: (2018-01-01)

Interactions between magnetic resonance imaging and dental material
by: Chalakuzhiyl Abraham Mathew, et al.
Published: (2013-01-01)

Anti-vascular agent Combretastatin A-4-P modulates Hypoxia Inducible Factor-1 and gene expression
by: Currie Margaret J, et al.
Published: (2006-12-01)

Anti-vascular agent Combretastatin A-4-P modulates hypoxia inducible factor-1 and gene expression
by: Dachs, Gabi U., et al.
Published: (2006)

Magnetic ressonance imaging contrast agents obtained by fast sonochemistry approach
by: Andrade Neto, Davino Machado
Published: (2017)

Cerebral Microbleeds, Vascular Risk Factors, and Magnetic Resonance Imaging Markers: The Northern Manhattan Study
by: Michelle R. Caunca, et al.
Published: (2016-09-01)

Diverse Responses to Vascular Disrupting Agent Combretastatin A4 Phosphate: A Comparative Study in Rats with Hepatic and Subcutaneous Tumor Allografts Using MRI Biomarkers, Microangiography, and Histopathology
by: Junjie Li, et al.
Published: (2013-02-01)

Local Vascularization during Orthodontic Tooth Movement in a Split Mouth Rat Model—A MRI Study
by: Peter Proff, et al.
Published: (2020-12-01)

Natural oral contrast agents for gastrointestinal magnetic resonance imaging
by: Mehrnaz Zarrini, et al.
Published: (2015-09-01)

Feasibility of multiparametric prostate magnetic resonance imaging in the detection of cancer distribution: histopathological correlation with prostatectomy specimens
by: Kosuke Kitamura, et al.
Published: (2014-12-01)

Combretastatin-Inspired Heterocycles as Antitubulin Anticancer Agents
by: Neha Hura, et al.
Published: (2018-08-01)